Similar articles

• C-peptide response to glucagon in diabetics with and without complications.

  Smith RB, Pyke DA, Watkins PJ, Binder C, Faber OK. Smith RB, et al. N Z Med J. 1979 Apr 25;89(634):304-6. N Z Med J. 1979. PMID: 377156
• C-peptide measurement and its clinical usefulness: a review.

  Bonser AM, Garcia-Webb P. Bonser AM, et al. Ann Clin Biochem. 1981 Jul;18(Pt 4):200-6. doi: 10.1177/000456328101800402. Ann Clin Biochem. 1981. PMID: 7025733 Review. No abstract available.
• [Plasma IRI--assay method and its significance].

  Kanazawa Y. Kanazawa Y. Nihon Rinsho. 1990 Feb;48 Suppl:3-6. Nihon Rinsho. 1990. PMID: 2192127 Japanese. No abstract available.
• [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].

  Santoro E, Gianni R, Maggi L, Tomassini CR, Bisacchi U. Santoro E, et al. G Clin Med. 1989 Feb;70(2):95-9. G Clin Med. 1989. PMID: 2666224 Italian.
• C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.

  Taskinen MR, Groop L. Taskinen MR, et al. Ann Clin Res. 1984;16(2):118-27. Ann Clin Res. 1984. PMID: 6380385 Review. No abstract available.